CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
Authors:
- Takahiko TokudaTTTakahiko Tokuda
- Mitsuhiro YoshitaMYMitsuhiro Yoshita
- Takashi KasaiTKTakashi Kasai
- Kenjiro OnoKOKenjiro Ono
- Masanori NakagawaMNMasanori Nakagawa
- Omar M.A. El-AgnafOEOmar M.A. El-Agnaf
- Masahito YamadaMYMasahito Yamada
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1251, 1-6
Abstract
No abstract availableKeywords
Funding Information
- United Arab Emirates University
- Faculty of Medical and Health Sciences, University of Auckland
- Parkinson's Disease Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 21 references indexed in Scilit:
- RETRACTED: Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances α-synuclein fibril formation in vitroExperimental Neurology, 2007
- Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s diseaseBiochemical and Biophysical Research Communications, 2006
- Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's diseaseThe FASEB Journal, 2006
- A clinical role for [123I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodiesJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Cardiac 123I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Lewy body variant of Alzheimerʼs diseaseNeuroReport, 2000
- A simple and efficient method for apolipoprotein E genotype determinationNeurology, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982
- “Mini-mental state”Journal of Psychiatric Research, 1975